MP27-11 DISTINCT SIDE EFFECT PROFILES AFTER CONTEMPORARY TREATMENT OF LOCALIZED PROSTATE CANCER
Karen E. Hoffman(The University of Texas MD Anderson Cancer Center), Amee Morgans(Nashville Oncology Associates), Tatsuki Koyama(Vanderbilt University Medical Center), Daniel A. Barocas(Vanderbilt University Medical Center), Sharon Phillips(Vanderbilt University Medical Center), JoAnn Alvarez(University of Bonn), David F. Penson(Geriatric Research Education and Clinical Center), Matthew J. Resnick(Vanderbilt University Medical Center)
Cited by 1
Related Papers
Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2019|1.6k
Long-Term Functional Outcomes after Treatment for Localized Prostate Cancer
|New England Journal of Medicine|2013|975
Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial
|The Lancet|2018|779
Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes
|European Urology|2015|688
Prostate Cancer, Version 1.2016
|Journal of the National Comprehensive Cancer Network|2016|656